Aparna Raychaudhuri

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Benjamin M. Segal, Cris S. Constantinescu, Aparna Raychaudhuri et al. · The Lancet Neurology · 2008 · 472 citations

Subcutaneous Injections, Autoimmune Disease, Systemic Scleroderma +10

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto, Daniel J. Lovell, Rubén Cuttica et al. · Arthritis & Rheumatism · 2007 · 403 citations

Lifitegrast for the Treatment of Dry Eye Disease

Edward J. Holland, Jodi Luchs, Paul Karpecki et al. · Ophthalmology · 2016 · 196 citations · Full text

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease

Joseph Tauber, Paul Karpecki, Robert Latkany et al. · Ophthalmology · 2015 · 186 citations · Full text

Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation

Stephanie N. Taylor, David H. Morris, Ann Avery et al. · Clinical Infectious Diseases · 2018 · 158 citations · Full text